| Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 … EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ... The Lancet Oncology 20 (7), 948-960, 2019 | 237 | 2019 |
| Molecular tests for colorectal cancer screening LJW Bosch, B Carvalho, RJA Fijneman, CR Jimenez, HM Pinedo, ... Clinical colorectal cancer 10 (1), 8-23, 2011 | 133 | 2011 |
| Genomic landscape of metastatic colorectal cancer JC Haan, M Labots, C Rausch, M Koopman, J Tol, LJM Mekenkamp, ... Nature communications 5 (1), 1-12, 2014 | 66 | 2014 |
| Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer EMV De Cuba, R Kwakman, M Van Egmond, LJW Bosch, HJ Bonjer, ... Virchows Archiv 461 (3), 231-243, 2012 | 65 | 2012 |
| Promoter CpG island hypermethylation-and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without … S Derks, LJW Bosch, HEC Niessen, PTM Moerkerk, SM Van Den Bosch, ... Carcinogenesis 30 (6), 1041-1048, 2009 | 64 | 2009 |
| DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT LJW Bosch, FA Oort, M Neerincx, CAJ Khalid-de Bakker, JST sive Droste, ... Cancer Prevention Research 5 (3), 464-472, 2012 | 60 | 2012 |
| Consensus molecular subtype classification of colorectal adenomas MA Komor, LJW Bosch, G Bounova, AS Bolijn, PM Delis‐van Diemen, ... The Journal of pathology 246 (3), 266-276, 2018 | 45 | 2018 |
| Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers EMV De Cuba, P Snaebjornsson, DAM Heideman, NCT Van Grieken, ... International journal of cancer 138 (5), 1139-1145, 2016 | 44 | 2016 |
| Multitarget stool DNA test performance in an average-risk colorectal cancer screening population LJW Bosch, V Melotte, S Mongera, KLJ Daenen, VMH Coupé, ... The American journal of gastroenterology 114 (12), 1909, 2019 | 40 | 2019 |
| Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer A Jacobsen, LJW Bosch, SR Martens-de Kemp, B Carvalho, ... Scientific reports 8 (1), 1-11, 2018 | 39 | 2018 |
| Fecal tests: from blood to molecular markers GP Young, LJW Bosch Current colorectal cancer reports 7 (1), 62-70, 2011 | 35 | 2011 |
| Novel stool-based protein biomarkers for improved colorectal cancer screening: a case–control study LJW Bosch, M De Wit, TV Pham, VMH Coupé, AC Hiemstra, SR Piersma, ... Annals of Internal Medicine 167 (12), 855-866, 2017 | 32 | 2017 |
| Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection LJW Bosch, S Mongera, FA Oort, ST van Turenhout, MT Penning, ... Cellular oncology 35 (4), 309-315, 2012 | 28 | 2012 |
| Cost-effectiveness of high-performance biomarker tests vs fecal immunochemical test for noninvasive colorectal cancer screening I Lansdorp-Vogelaar, SL Goede, LJW Bosch, V Melotte, B Carvalho, ... Clinical gastroenterology and hepatology 16 (4), 504-512. e11, 2018 | 27 | 2018 |
| Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression MA Komor, LJW Bosch, VMH Coupé, C Rausch, TV Pham, SR Piersma, ... The Journal of pathology 250 (3), 288-298, 2020 | 20 | 2020 |
| Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE) KG Samsom, LJW Bosch, LJ Schipper, P Roepman, E de Bruijn, LR Hoes, ... BMC medical genomics 13 (1), 1-7, 2020 | 16 | 2020 |
| Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study SJ Schraa, KL Van Rooijen, DEW Van Der Kruijssen, C Rubio Alarcón, ... BMC cancer 20 (1), 1-10, 2020 | 16 | 2020 |
| Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPK D Fontijn, LJW Bosch, MCA Duyndam, MPA van Berkel, ML Janmaat, ... Analytical Cellular Pathology 31 (3), 179-190, 2009 | 16* | 2009 |
| Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer LJW Bosch, G Trooskens, P Snaebjornsson, VMH Coupé, S Mongera, ... Oncotarget 8 (38), 63140, 2017 | 13 | 2017 |
| Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) AdenomasCancer-Associated DNA Copy Numbers in Colorectal Adenomas B Carvalho, B Diosdado, JS Terhaar Sive Droste, AS Bolijn, MA Komor, ... Cancer Prevention Research 11 (7), 403-412, 2018 | 11 | 2018 |
Gerrit A Meijerprofessor of oncologic pathology, Netherlands Cancer Institute, AmsterdamGeverifieerd e-mailadres voor nki.nl
